Daniel M. Ramos, DDS, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Daniel M. Ramos, DDS, PhD

Associate Professor, Department of Orofacial Sciences, UCSF

daniel.ramos@ucsf.edu

Phone: (415) 502-4905 (voice)
Box 0512, UCSF
San Francisco, CA 94143-0512

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Education

California State University, Los Angeles, B.S., 1984, Biology
University of California, San Francisco, D.D.S., 1988, Dentistry
University of California, San Francisco, Ph.D., 1994, Oral Biology


Professional Experience

  • 1983-84
    Lab Assistant, Independent Research Project: Tyrosinase Levels in Avian Tissues, California State University, Los Angeles, Department of Biology, Advisor: Dr. Roger Bowers
  • 1985-94
    Postgraduate Research Dentist, University of California, San Francisco, Dept. of Stomatology, Advisor: Dr. Randall Kramer
  • 1994-97
    Adjunct Assistant Professor, University of California, San Francisco, Dept. of Stomatology
  • 1997-2003
    Assistant Professor, University of California, San Francisco, Dept. of Stomatology
  • 2003-present
    Associate Professor, University of California, San Francisco, Department of Stomatology

Honors & Awards

  • 1988-93
    Individual Dentist Scientist Award, NIH-NIDR 1K15DE00242
  • 1995-96
    Junior Faculty Development Award (Academic Senate)
  • 2001
    Dean's Creativity Award (School of Dentistry)

Selected Publications

  1. Differential diagnosis and management of oral ulcers. Semin Cutan Med Surg. 2015 Dec; 34(4):171-7.
    View on PubMed
  2. Differential spheroid formation by oral cancer cells. Anticancer Res. 2014 Dec; 34(12):6945-9.
    View on PubMed
  3. Wnt signaling regulates pulp volume and dentin thickness. J Bone Miner Res. 2014 Apr; 29(4):892-901.
    View on PubMed
  4. The cytoplasmic extension of the integrin ß6 subunit regulates epithelial-to-mesenchymal transition. Anticancer Res. 2014 Feb; 34(2):659-64.
    View on PubMed
  5. Expression of EMMPRIN modulates mediators of tumor invasion in oral squamous cell carcinoma. J Calif Dent Assoc. 2013 Nov; 41(11):831-8.
    View on PubMed
  6. Alphavbeta3 suppresses the RhoA-LIMK1 pathway in K1735 melanoma. J Calif Dent Assoc. 2012 Dec; 40(12):921-7.
    View on PubMed
  7. Revisiting epithelial-to-mesenchymal transition through adenoid cystic carcinoma. Anticancer Res. 2012 Sep; 32(9):3683-8.
    View on PubMed
  8. Stem cell markers as predictors of oral cancer invasion. Anticancer Res. 2012 Apr; 32(4):1163-6.
    View on PubMed
  9. EMMPRIN expression in oral SCC is regulated by FYN kinase. Anticancer Res. 2011 Apr; 31(4):1205-9.
    View on PubMed
  10. Expression of Fyn kinase modulates EMT in oral cancer cells. Anticancer Res. 2010 Jul; 30(7):2591-6.
    View on PubMed
  11. Modulation of EGFR by oral squamous cell carcinoma cell lines. J Calif Dent Assoc. 2009 Dec; 37(12):869-74.
    View on PubMed
  12. Identification of {alpha}v{beta}6-positive stem cells in oral squamous cell carcinoma. Anticancer Res. 2009 Jun; 29(6):2043-9.
    View on PubMed
  13. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer. Anticancer Res. 2009 Jan; 29(1):125-30.
    View on PubMed
  14. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma. Anticancer Res. 2008 Jul-Aug; 28(4B):2049-54.
    View on PubMed
  15. Hair cycle and wound healing in mice with a keratinocyte-restricted deletion of FAK. Oncogene. 2006 Feb 16; 25(7):1081-9.
    View on PubMed
  16. Alphavbeta3 integrin and cofilin modulate K1735 melanoma cell invasion. Exp Cell Res. 2006 Feb 15; 312(4):468-77.
    View on PubMed
  17. The expression of integrin alpha(v)beta6 promotes the epithelial cell morphology and suppresses invasive behavior in transformed oral keratinocytes. Anticancer Res. 2005 Mar-Apr; 25(2A):751-5.
    View on PubMed
  18. Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms. Oral Oncol. 2005 Feb; 41(2):170-4.
    View on PubMed
  19. Tenascin-C deposition requires beta3 integrin and Src. Biochem Biophys Res Commun. 2004 Sep 24; 322(3):935-42.
    View on PubMed
  20. Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix. Biochem Biophys Res Commun. 2004 Apr 9; 316(3):937-42.
    View on PubMed

Go to UCSF Profiles, powered by CTSI